Genmab AS Cash Flow Quality Index
Genmab AS cash flow quality index. Genmab AS (GMAB) has a Cash Flow Quality Index of 9.72x as of December 2025. Operating cash flow of $300.34 Million exceeds net income of $30.91 Million, indicating high earnings quality where cash backs reported profits. See GMAB financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Genmab AS (2013–2025)
Cash flow quality index of Genmab AS from 2013 to 2025. Historical Cash Flow Quality Index for Genmab AS across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Genmab AS (GMAB) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Genmab AS Cash Flow Quality Index by Year (2013–2025)
Genmab AS cash flow quality index by year from 2013 to 2025. Year-by-year earnings quality comparison for Genmab AS. For the full cash flow conversion analysis, see Genmab AS cash conversion from operations.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.23x | $1.19 Billion | $963.76 Million | ▲ +24.3% |
| 2024 | 0.99x | $7.77 Billion | $7.84 Billion | ▼ -24.3% |
| 2023 | 1.31x | $7.38 Billion | $5.64 Billion | ▲ +135.4% |
| 2022 | 0.56x | $3.91 Billion | $7.04 Billion | ▼ -0.6% |
| 2021 | 0.56x | $2.23 Billion | $3.98 Billion | ▼ -58.6% |
| 2020 | 1.35x | $6.43 Billion | $4.76 Billion | ▲ +191.5% |
| 2019 | 0.46x | $1.33 Billion | $2.86 Billion | ▼ -26.3% |
| 2018 | 0.63x | $1.01 Billion | $1.61 Billion | ▼ -57.9% |
| 2017 | 1.49x | $1.59 Billion | $1.06 Billion | ▲ +415.2% |
| 2016 | 0.29x | $327.72 Million | $1.13 Billion | ▼ -29.5% |
| 2015 | 0.41x | $311.45 Million | $757.53 Million | ▼ -7.9% |
| 2014 | 0.45x | $132.67 Million | $297.35 Million | ▲ +137.5% |
| 2013 | -1.19x | $-128.00 Million | $107.64 Million | — |